Cotinga Pharmaceuticals Provides Update on COTI-2 Clinical Programs
20. März 2018 07:00 ET
|
Cotinga Pharmaceuticals Inc.
LONDON, Ontario and BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...